CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 183.4	$ 488.3
Accounts receivable, net	565.5	492.0
Inventories	1,067.8	968.3
Other current assets	236.5	215.6
Total current assets	2,053.2	2,164.2
Property, plant and equipment, net	669.3	599.7
Goodwill	1,507.3	582.6
Intangible assets, net	912.5	330.5
Operating lease assets	145.5	91.7
Deferred tax assets, net	286.2	297.2
Other long-term assets	232.7	184.0
Total assets	5,806.7	4,249.9
Current liabilities:
Current portion of long-term debt and finance lease obligations	32.5	121.2
Accounts payable	234.1	202.7
Deferred revenue and customer advances	438.2	400.0
Other current liabilities	576.5	478.2
Total current liabilities	1,281.3	1,202.1
Long-term debt	2,061.8	1,160.3
Long-term deferred revenue and customer advances	100.0	91.5
Deferred tax liabilities	118.5	67.7
Operating lease liabilities	118.9	74.8
Other long-term liabilities	311.0	240.2
Total liabilities	3,991.5	2,836.6
Commitments and contingencies (Note 26)
Redeemable noncontrolling interests	18.1	18.7
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2024 and 2023	0.0	0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 182,456,831 and 175,943,705 shares issued and 151,677,952 and 145,164,826 outstanding at December 31, 2024 and 2023, respectively	1.8	1.7
Treasury stock at cost, 30,778,879 shares at December 31, 2024 and 2023	(1,237.2)	(1,237.2)
Additional paid-in capital	713.4	282.9
Retained earnings	2,406.7	2,323.8
Accumulated other comprehensive income (loss), net of tax	(103.5)	6.0
Total shareholders' equity attributable to Bruker Corporation	1,781.2	1,377.2
Noncontrolling interests in consolidated subsidiaries	15.9	17.4
Total shareholders' equity	1,797.1	1,394.6
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 5,806.7	$ 4,249.9